Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is experiencing robust growth across its Financial Services Provider (FSP), Real World Evidence (RWE), and Contract Sales Management Services (CSMS) segments, indicating strong year-over-year performance in the third quarter. The company has demonstrated improving client decision timelines and a healthy pipeline, driven by recent drug launches, complemented by a significant increase in requests for proposals (RFPs) and an improved win rate in key segments. Additionally, IQVIA anticipates a continued positive trajectory with a projected growth rate of over 4% in its research and development services on a constant currency basis, bolstered by a favorable pricing environment.

Bears say

The financial analysis of IQVIA Holdings reveals a concerning trend in revenue growth, with a decline in year-over-year constant currency growth from 6.8% in 2Q25 to 3.8% in the most recent quarter. The company is facing difficult year-over-year comparisons and has expressed disappointment over potential growth falling below 5% in 2026, highlighting concerns about revenue stability moving forward. Additionally, operational challenges such as reduced hiring, pressures from passthroughs on margins, and the impact of rising interest rates on earnings further contribute to a negative outlook for the stock.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.